Elicio Therapeutics to Present New Preliminary Data from the

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Chicago , Illinois , United States , Boston , Massachusetts , American , Craige Devoe , Heather Divecchia , American Society Of Clinical Oncology , Securities Exchange , Nasdaq , Elicio Therapeutics Inc , Northwell Health , Rj Zuckerberg Cancer Center , Lifesci Communications , Division Of Medical Oncology Hematology , Present New Preliminary Data , Solid Tumors , Clinical Oncology , Annual Meeting , Poster Session , Developmental Therapeutics , Medical Oncology , Scientific Investigator , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report ,